Epoch Investment Partners’s Maravai LifeSciences MRVI Stock Holding History

Epoch Investment Partners’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-101,308	Closed	-$725K	–	386
2024 Q2	$725K	Sell	101,308 -178,124	-64%	-$1.54M	﹤0.01%	325
2024 Q1	$2.42M	Sell	279,432 -1,102,139	-80%	-$7.46M	0.01%	290
2023 Q4	$9.05M	Sell	1,381,571 -160,020	-10%	-$1.03M	0.04%	267
2023 Q3	$15.4M	Buy	1,541,591 +411,758	+36%	+$4.52M	0.1%	212
2023 Q2	$14M	Buy	1,129,833 +69,787	+7%	+$942K	0.08%	228
2023 Q1	$14.9M	Buy	1,060,046 +14,546	+1%	+$209K	0.09%	217
2022 Q4	$15M	Buy	+1,045,500	New	+$16.5M	0.09%	225

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Epoch Investment Partners's MRVI Position: Q3 2024 in Review

Epoch Investment Partners sold out of Maravai LifeSciences (MRVI) in Q3 2024, closing a stake of 101,308 shares — an estimated $725K sold.

Epoch Investment Partners first reported a position in MRVI in Q4 2022 and held it in 7 quarters. The position peaked at $15.4M in Q3 2023. 217 funds tracked by Wall St. Rank hold MRVI as of Q3 2024.

Epoch Investment Partners reported no remaining Maravai LifeSciences position as of Q3 2024 after selling out during the quarter.
Epoch Investment Partners sold 101,308 Maravai LifeSciences shares in Q3 2024, an estimated $725K.
Epoch Investment Partners first reported a position in Maravai LifeSciences in Q4 2022 and held it in 7 quarters.
Epoch Investment Partners's Maravai LifeSciences position peaked at $15.4M in Q3 2023.
217 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2024.

Based on Epoch Investment Partners's 13F filing for Q3 2024, filed 13 Nov 2024.